News

Featured News

  • 2026 |
  • 2025 |
  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | October 9, 2026

    TRexBio Announces Pricing of Initial Public Offering

    Read More

    Press Release | October 5, 2026

    Introducing Fierce Biotech’s 2026 Fierce 15

    Read More

    Press Release | July 27, 2026

    FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

    Read More

    Press Release | July 21, 2026

    Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

    Read More